Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1456 of 6351
-
New hope for PNH patients: experimental drug HS-10542 enters human trials
Disease control Recruiting nowThis was a phase 1b/2,open label, multi-center study to assess efficacy and safety of HS-10542 in adulte patients with paroxysmal nocturnal hemoglobinuria (PNH) with signs of active hemolysis.
Phase 1/2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New smart drug targets tough cancers in first human trial
Disease control Recruiting nowThe purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in participants with locally advanced or metastatic solid tumors with known Ly6E expression, including non-small cell lung can…
Phase 1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 10, 2026 12:00 UTC
-
New weekly shot could fight deadly mould infections with fewer side effects
Disease control Recruiting nowThe purpose of this study is to determine if EL219 is safe and effective compared to liposomal amphotericin B (LAmB) or voricanozole for early treatment of invasive mould infections
Phase 2 • Sponsor: Elion Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Cancer-Killing virus takes on ovarian cancer in first human trial
Disease control Recruiting nowA research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer. The trial will investigate different doses of THEO-260 administered by the intraperitoneal route to identify a dose that is safe, well tolerated, and exhibits preliminary eviden…
Phase 1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot could boost opioid recovery, early trial hopes
Disease control Recruiting nowThe purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug HU6 targets fatty liver disease in Mid-Stage trial
Disease control Recruiting nowRivus Pharmaceuticals. Inc. is sponsoring this research study to assess the safety and tolerability of HU6 as a possible treatment for patients diagnosed with metabolic dysfunction-associated steatohepatitis (MASH). The study will also assess safety, pharmacokinetics (PK) and cha…
Phase 2 • Sponsor: Rivus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New stroke trial aims to restore blood flow in tiny brain vessels
Disease control Recruiting nowThis is a prospective, single-arm, open-label study to evaluate the efficacy of intra-arterial tenecteplase in improving microvascular reperfusion following successful large vessel recanalization. Acute ischemic stroke patients with large anterior circulation large vessel occlusi…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Beauty salons join fight against HIV: new online program aims to boost PrEP use among black women
Prevention Recruiting nowThe goal of this clinical trial is to test a new online program called UPDOs Protective Styles to help people in the southeastern United States learn about and start using PrEP (pre-exposure prophylaxis), a medicine that helps prevent HIV. The study focuses on people who may be a…
Sponsor: Duke University • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take on pancreatic cancer in early trial
Disease control Recruiting nowThis is a single-center, open-label, first-in-human, fixed-dose study in patients with pancreatic cancer.
Phase 1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New heart ablation waveforms aim to tame atrial fibrillation
Disease control Recruiting nowThis is a multicenter, prospective, single-arm, feasibility study to evaluate the safety and effectiveness of the waveforms being delivered using the FARAPULSE PFA System in patients with Paroxysmal Atrial Fibrillation (PAF) and Persistent Atrial Fibrillation (PersAF).
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers with RAS mutations
Disease control Not yet recruitingEvaluate the safety and tolerability of BPI-572270 in adult patients with specific RAS mutant advanced solid tumors.
Phase 1/2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Smart robotic hand learns to grip objects for amputees
Disease control OngoingThe purpose of this research is to create an intelligent robotic hand for people who have lost a limb below their elbow. By using artificial intelligence to adaptively grasp different types of objects, this will improve both the accuracy and flexibility of robotic prosthetic cont…
Sponsor: Al-Nahrain University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for rare penile cancer: targeted drug combo shows promise
Disease control Recruiting nowPenile squamous cell carcinoma (PSCC) is a rare malignancy, with stage IV patients exhibiting a 2-year overall survival (OS) rate of 21% and a 5-year survival rate of 0%. Both the National Comprehensive Cancer Network (NCCN) and European Association of Urology (EAU) guidelines re…
Phase 1 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a chat program help young smokers quit for good?
Disease control Recruiting nowThe health benefits of smoking cessation by age 30 are much greater than cessation later in life, including gaining 10 years of life, compared with those who continue to smoke. The goal of the proposed study is to evaluate the effectiveness of the bilingual and culturally tailore…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New program bridges schools and clinics to tame childhood asthma
Disease control Recruiting nowThe overall goal of this research study is to evaluate a multi-level program called PRAGMATIC-S to improve the delivery of guideline-based asthma care through a unique partnership between clinical practices and schools. PRAGMATIC-S represents a novel approach that addresses multi…
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New lupus drug candidate D-2570 enters Mid-Stage trial
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of D-2570 in the treatment of active systemic lupus erythematosus.
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a tiny dose of a diabetes drug stop weight regain in HIV patients?
Disease control Recruiting nowThe objectives of this study are as follows: Primary Objective * To determine the rate of weight regain in people living with human immunodeficiency virus (HIV) (PWH) receiving semaglutide microdosing vs. no additional drug following induction therapy. Secondary Objectives * …
Phase 2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThe goal of this clinical research study is to learn about the safety and effects of BMS-986504 in combination with olaparib in patients with advanced solid tumors with MTAP loss.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can red light stop severe nearsightedness from worsening in adults?
Disease control Not yet recruitingThis study, led by Jie ying from the Ophthalmology Department of Beijing Tongren Hospital Affiliated to Capital Medical University, is a researcher-initiated clinical trial (IIT) designed to evaluate the therapeutic efficacy of low-intensity red light therapy in adult patients wi…
Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo therapy aims to improve sarcoma surgery outcomes
Disease control Not yet recruitingTo investigate the feasibility and peri-operative complications of preoperative hypo-fractionated radiotherapy combined with immunotherapy followed by surgery for retroperitoneal sarcoma
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC